While reduced expression of either SCN1B/β1 or SCN2B/β2 decreased cancer cell invasiveness through Matrigel-coated invasion chambers by 42.8±6.6% (n=8) and 51.7±0.3% (n=8) (mean±s.e.m. The gene discussed is SCN2B; the disease is cancer.